Sunmax Biotechnology

Sunmax Biotechnology is a Taiwan-based medical device and biotechnology company specializing in the development and manufacture of high-purity collagen-based products. The company utilizes a proprietary extraction and cross-linking technology to produce medical-grade Type I collagen derived from porcine sources. Its product portfolio includes injectable dermal fillers for aesthetic medicine, bone graft substitutes for orthopedics, and membranes for dental applications. Sunmax is vertically integrated, maintaining its own GMP-certified manufacturing facilities to ensure the safety and biocompatibility of its biomaterials. The company serves global markets, focusing on regenerative medicine and aesthetic dermatology. It is publicly traded on the Taipei Exchange and continues to expand its collagen applications into ophthalmology and advanced wound care.